Cargando…

Patients’ attitude towards a sham-controlled trial on pulmonary vein isolation in atrial fibrillation

BACKGROUND: The interpretation of recent trials on pulmonary vein ablation (PVI) for the treatment of atrial fibrillation (AF) is hampered by the lack of blinding and sham controls. The feasibility of a sham-controlled trial has been questioned. We aimed to assess the attitude of potential participa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uhe, Tobias, Beimel, Samira, Langhammer, Romy, Stegmann, Tina, Hindricks, Gerhard, Laufs, Ulrich, Dagres, Nikolaos, Wachter, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766391/ https://www.ncbi.nlm.nih.gov/pubmed/34709451 http://dx.doi.org/10.1007/s00392-021-01959-z

Ejemplares similares

Signs of left atrial disease and 10-year risk of atrial fibrillation
por: Uhe, Tobias, et al.
Publicado: (2022)

Heart failure patients with atrial fibrillation benefit from remote patient management: insights from the TIM‐HF2 trial
por: Stegmann, Tina, et al.
Publicado: (2020)

Early detection of atrial fibrillation in patients with heart failure reduces the risk of subsequent hospitalization: a subanalysis of the randomized TIM-HF2 trial
por: Stegmann, Tina, et al.
Publicado: (2022)

Sleep Disorders and Atrial Fibrillation: Current Situation and Future Directions
por: Sepehri Shamloo, Alireza, et al.
Publicado: (2018)

Exercise and Atrial Fibrillation: Some Good News and Some Bad News
por: Sepehri Shamloo, Alireza, et al.
Publicado: (2018)

Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation
por: Ueberham, Laura, et al.
Publicado: (2017)

Rate of acquired pulmonary vein stenosis after ablation of atrial fibrillation referred to electroanatomical mapping systems: Does it matter?
por: Schoene, Katharina, et al.
Publicado: (2019)

Catheter ablation for atrial fibrillation: impact on mortality, morbidity, quality of life, and implications for the future
por: Dilk, Patrick, et al.
Publicado: (2022)

Initial rivaroxaban dosing in patients with atrial fibrillation
por: Ablefoni, Kaja, et al.
Publicado: (2019)

Collateral damage: Fear from SARS-CoV2-infection causing Takotsubo cardiomyopathy
por: Uhe, Tobias, et al.
Publicado: (2020)

Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation
por: Schumacher, Katja, et al.
Publicado: (2018)

Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy
por: Nedios, Sotirios, et al.
Publicado: (2021)

Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and meta-analysis
por: Sepehri Shamloo, Alireza, et al.
Publicado: (2019)

Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?
por: Nedios, Sotirios, et al.
Publicado: (2020)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
por: Werhahn, Stefanie M., et al.
Publicado: (2021)

Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation
por: Seewöster, Timm, et al.
Publicado: (2018)

A randomized sham‐controlled study of pulmonary vein isolation in symptomatic atrial fibrillation (The SHAM‐PVI study): Study design and rationale
por: Dulai, Rajdip, et al.
Publicado: (2023)

Are the atrial natriuretic peptides a missing link predicting low‐voltage areas in atrial fibrillation? Introducing the novel biomarker‐based atrial fibrillation substrate prediction (ANP) score
por: Seewöster, Timm, et al.
Publicado: (2020)

P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis
por: Intzes, Stergios, et al.
Publicado: (2022)

Revisited Upper Reference Limits for Highly Sensitive Cardiac Troponin T in Relation to Age, Sex, and Renal Function
por: Gärtner, Christiane, et al.
Publicado: (2021)

The PROFID project
por: Dagres, Nikolaos, et al.
Publicado: (2020)

Impact of single versus double transseptal puncture on outcome and complications in pulmonary vein isolation procedures
por: Stauber, Annina, et al.
Publicado: (2020)

Catheter ablation of atrial fibrillation: recent advances and future challenges
por: Hindricks, Gerhard, et al.
Publicado: (2022)

Flecainide-Associated Cardiogenic Shock in a Patient with Atrial Fibrillation
por: Gjermeni, Erind, et al.
Publicado: (2019)

C-kit(pos) cells in the human left atrial appendage
por: Schwarzkopf, Lea, et al.
Publicado: (2023)

Arginine derivatives in atrial fibrillation progression phenotypes
por: Büttner, Petra, et al.
Publicado: (2020)

Clinical Implications of Recent Trials on Anticoagulation in Patients with Atrial Fibrillation
por: Arya, Arash, et al.
Publicado: (2012)

Moving catheter ablation forward from paroxysmal to persistent atrial fibrillation: progress, limitations, and surprises of the SARA trial
por: Hindricks, Gerhard, et al.
Publicado: (2014)

Heart failure is independently associated with white matter lesions: insights from the population‐based LIFE‐Adult Study
por: Stegmann, Tina, et al.
Publicado: (2020)

Anti-inflammatory HDL effects are impaired in atrial fibrillation
por: Holzwirth, Erik, et al.
Publicado: (2021)

Trimethylamine N-oxide in atrial fibrillation progression
por: Büttner, Petra, et al.
Publicado: (2020)

Correction to: Arginine derivatives in atrial fibrillation progression phenotypes
por: Büttner, Petra, et al.
Publicado: (2021)

Association of atrial fibrillation susceptibility genes, atrial fibrillation phenotypes and response to catheter ablation: a gene-based analysis of GWAS data
por: Husser, Daniela, et al.
Publicado: (2017)

Biatrial volume ratio predicts low voltage areas in atrial fibrillation
por: Seewöster, Timm, et al.
Publicado: (2021)

P-wave duration and interatrial block as predictors of new-onset atrial fibrillation: A systematic review and meta-analysis
por: Koutalas, E, et al.
Publicado: (2023)

Subject-Specific Calculation of Left Atrial Appendage Blood-Borne Particle Residence Time Distribution in Atrial Fibrillation
por: Sanatkhani, Soroosh, et al.
Publicado: (2021)

Focal Impulse and Rotor Modulation Ablation vs. Pulmonary Vein isolation for the treatment of paroxysmal Atrial Fibrillation: results from the FIRMAP AF study
por: Tilz, Roland R, et al.
Publicado: (2020)

Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator
por: Hadwiger, Moritz, et al.
Publicado: (2020)

Long-term Success and Follow-up After Atrial Fibrillation Ablation
por: Kircher, S, et al.
Publicado: (2012)

Lobectomy due to Pulmonary Vein Occlusion after Radiofrequency Ablation for Atrial Fibrillation
por: Papakonstantinou, Nikolaos A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1aoe1aqqftkutmtthglviaivog